Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 26, 2021	Dec. 27, 2020	Dec. 29, 2019
Operating activities
Net income before attribution to noncontrolling interests	$ 124,955	$ 60,614	$ 5,657
Adjustments to reconcile net income to net cash provided by operating activities:
(Benefit) provision for allowance for credit losses on accounts and notes receivable	(852)	(4,734)	3,139
Depreciation and amortization	48,816	49,705	47,281
Deferred income taxes	3,753	(9,268)	(3,764)
Preferred stock option mark-to-market adjustment			5,914
Stock-based compensation expense	16,919	16,310	15,303
(Gain) on refranchising			(4,739)
Other	581	2,257	3,203
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable	4,023	(22,420)	(6,181)
Income tax receivable	(8,113)	3,760	12,122
Inventories	(4,708)	(2,736)	(326)
Prepaid expenses and other current assets	2,866	2,884	1,367
Other assets and liabilities	(20,077)	20,879	(6,354)
Accounts payable	(9,278)	8,229	2,035
Income and other taxes payable	9,733	2,664	1,009
Accrued expenses and other current liabilities	15,875	59,353	(11,331)
Deferred revenue	182	(1,058)	(2,586)
Net cash provided by operating activities	184,675	186,439	61,749
Investing activities
Purchases of property and equipment	(68,559)	(35,652)	(37,711)
Notes issued	(16,132)	(16,589)	(15,864)
Repayments of notes issued	18,555	11,154	5,616
Acquisitions, net of cash acquired	(699)
Proceeds from divestitures of restaurants			13,495
Other	3,323	16	1,889
Net cash used in investing activities	(63,512)	(41,071)	(32,575)
Financing activities
Proceeds from issuance of senior notes	400,000
Repayments of term loan	(340,000)	(20,000)	(15,000)
Net proceeds (repayments) of revolving credit facilities	80,000		(240,026)
Debt issuance costs	(9,179)
Repurchase of Series B Convertible Preferred Stock	(188,647)
Proceeds from issuance of Series B Convertible Preferred Stock			252,530
Issuance costs associated with Series B Convertible Preferred Stock			(7,527)
Acquisition of Company common stock	(72,499)	(2,701)
Proceeds from exercise of stock options	11,969	30,622	16,010
Dividends paid to common stockholders	(40,356)	(29,362)	(28,552)
Dividends paid to preferred stockholders	(6,394)	(13,649)	(10,020)
Tax payments for equity award issuances	(5,847)	(3,974)	(1,433)
Contributions from noncontrolling interests			840
Distributions to noncontrolling interests	(5,942)	(2,420)	(870)
Other	(3,631)	(1,977)	(526)
Net cash used in financing activities	(180,526)	(43,461)	(34,574)
Effect of exchange rate changes on cash and cash equivalents	(231)	386	53
Change in cash and cash equivalents	(59,594)	102,293	(5,347)
Cash and cash equivalents at beginning of period	130,204	27,911	33,258
Cash and cash equivalents at end of period	$ 70,610	$ 130,204	$ 27,911